the PROTECT study

about the study

There are many unanswered questions about the process of reducing and stopping psychiatric medicines (commonly referred to as 'tapering') and how best to do it. We think that it is important that future research focuses on the questions that are important to people with lived experience of taking and/or stopping any of these medicines, family members, carers/supporters and healthcare professionals.

The PROTECT study team, in partnership with the James Lind Alliance, has set up this priority setting partnership to identify the Top 10 priorities for future research about reducing and stopping psychiatric medicines. This study could help to change the research agenda which will allow future research to focus on the most important questions. 

For more information about the James Lind Alliance and the methods we are using, go to

Study Progress to date

In the Round 1 survey, we collected questions and uncertainties that people have about reducing and stopping psychiatric medicines. These people included individuals with lived experience of taking and/or stopping psychiatric medicines, family members, carers/supporters, and healthcare professionals. Then, through a process of analysis and consultation with the project’s Steering Group we have come up with 32 potential research questions.
Now as part of the Round 2 survey, you are invited to select up to 10 questions that you think are the most important for future research.